Insider Selling: Omada Health (NASDAQ:OMDA) CFO Sells $148,648.00 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 6,800 shares of Omada Health stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $21.86, for a total value of $148,648.00. Following the sale, the chief financial officer owned 173,906 shares of the company’s stock, valued at approximately $3,801,585.16. This represents a 3.76% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Omada Health Trading Up 0.5%

NASDAQ:OMDA opened at $19.76 on Thursday. The firm has a market cap of $1.21 billion, a price-to-earnings ratio of 395.20 and a beta of 1.86. The company’s 50-day moving average is $22.45 and its two-hundred day moving average is $18.14. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $26.92.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.08 EPS for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.10. The business had revenue of $87.83 million during the quarter, compared to the consensus estimate of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. On average, equities research analysts forecast that Omada Health, Inc. will post 0.09 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Barclays boosted their price target on Omada Health from $25.00 to $27.00 and gave the company an “overweight” rating in a report on Friday, September 11th. Weiss Ratings raised Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research report on Tuesday, August 11th. Robert W. Baird upped their target price on Omada Health from $15.00 to $25.00 and gave the company a “neutral” rating in a research note on Wednesday, August 12th. BMO Capital Markets reissued an “outperform” rating and issued a $24.00 price target on shares of Omada Health in a research note on Friday, August 7th. Finally, Canaccord Genuity Group lifted their price target on Omada Health from $24.00 to $28.00 and gave the company a “buy” rating in a report on Tuesday, July 21st. Eleven research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Omada Health presently has an average rating of “Moderate Buy” and a consensus price target of $26.67.

Institutional Trading of Omada Health

Several institutional investors have recently made changes to their positions in the stock. WINTON GROUP Ltd acquired a new stake in shares of Omada Health during the 2nd quarter worth $1,101,000. Integrated Wealth Concepts LLC acquired a new position in Omada Health in the second quarter valued at $53,000. Squarepoint Ops LLC purchased a new stake in Omada Health during the second quarter valued at about $2,044,000. Corient Private Wealth LP grew its position in Omada Health by 252.5% during the second quarter. Corient Private Wealth LP now owns 145,118 shares of the company’s stock valued at $3,185,000 after acquiring an additional 103,955 shares during the period. Finally, Round Rock Advisors LLC acquired a new stake in Omada Health during the second quarter worth about $745,000.

About Omada Health

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.

The company’s offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada’s programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.

Omada primarily serves members through employers, health plans and healthcare organizations in the United States.